Historial de carrera de Gregory M. Torre
Antiguos cargos conocidos de Gregory M. Torre.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director/Miembro de la Junta | 29/12/2017 | 27/04/2018 |
| Director Técnico/Científico/I+D | 29/12/2017 | 27/04/2018 | |
| Consejero General | 29/12/2017 | 27/04/2018 | |
| NPS PHARMACEUTICALS, INC. | Consejero General | 01/02/2006 | 31/07/2007 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Consejero General | 22/12/2010 | - |
| Corporate Officer/Principal | - | - |
Formación de Gregory M. Torre.
| St. John's University | Doctorate Degree |
| Brooklyn Law School | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| General Counsel | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory M. Torre
- Experiencia
